Apr 18, 2024
|
Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
|
Mar 28, 2024
|
Ardelyx, Inc. Reports Employment Inducement Grants
|
Mar 25, 2024
|
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy
|
Mar 12, 2024
|
Ardelyx, Inc. Reports Employment Inducement Grants
|
Feb 27, 2024
|
Ardelyx to Participate at the Cowen 44th Annual Health Care Conference
|
Feb 22, 2024
|
Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
|
Feb 1, 2024
|
Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
|
Jan 12, 2024
|
Ardelyx, Inc. Reports Employment Inducement Grants
|
Jan 8, 2024
|
Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities
|
Jan 3, 2024
|
Ardelyx to Provide Company Update on IBSRELA® and Host a KOL Discussion on the IBS-C Landscape on Monday, January 8
|